Abeona Therapeutics Inc.
ABEO· Nasdaq
Released May 15, 2017, after the close
10-Q filed May 15, 2017, 45 days after period end · 0001144204-17-027498
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $186.00K | $235.00K | $258.00K | $208.00K |
| Net Income | -$5.25M | -$5.54M | -$2.00M | -$859.00K |
| EPS Diluted | -$0.13 |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.10 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.